NCT00525057View on ClinicalTrials.gov

Dalteparin in Preventing DVT in Participants With Cancer

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 7, 2006

Primary Completion Date

June 19, 2020

Study Completion Date

June 19, 2020

Conditions
Bone SarcomaFemur FractureLymphomaMetastatic NeoplasmPathologic FracturePlasma Cell MyelomaSoft Tissue Sarcoma
Interventions
DRUG

Dalteparin

Given SC

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00525057 - Dalteparin in Preventing DVT in Participants With Cancer | Biotech Hunter | Biotech Hunter